Welcome to our dedicated page for Waters news (Ticker: WAT), a resource for investors and traders seeking the latest updates and insights on Waters stock.
Waters Corporation (NYSE: WAT), a global leader in analytical instrumentation and laboratory technologies, provides critical solutions for pharmaceutical development, food safety testing, and environmental monitoring. This dedicated news hub aggregates official announcements, financial disclosures, and strategic updates directly impacting the company's market position and technological advancements.
Investors and industry professionals will find curated updates including quarterly earnings reports, product innovation announcements, executive leadership changes, and regulatory developments. Our repository ensures timely access to filings, partnership agreements, and scientific breakthroughs related to Waters' chromatography systems, mass spectrometry platforms, and thermal analysis instruments.
Key content categories include financial performance updates, new product launches, research collaborations, and operational expansions. Bookmark this page to monitor developments affecting Waters' role in life sciences R&D, quality assurance protocols, and laboratory informatics solutions across 100+ countries.
Waters Corporation (NYSE:WAT), a global leader in analytical instruments and technologies, has scheduled its Q2 2025 earnings conference call for Monday, August 4th, 2025, at 8:00 a.m. Eastern Time. The presentation will be accessible through a live webcast on the company's investor relations website.
The webcast replay will remain available until September 2nd, 2025. Waters Corporation serves life, materials, food, and environmental sciences sectors with over 7,600 employees operating in more than 100 countries, focusing on medicine efficacy, food safety, water purity, and product quality.
Waters Corporation (NYSE:WAT) has acquired Halo Labs, a company specializing in imaging technologies for particle analysis in therapeutic products. The acquisition brings Halo's Aura™ platform, which offers full spectrum particle analysis capabilities complementary to Waters' existing Wyatt Technology™ Portfolio.
The Aura platform's key advantage lies in its ability to detect translucent process impurities in CAR T-cell therapies that are typically undetectable through standard methods. This technology will be integrated into Waters' large molecule development and QA/QC processes, enhancing their analytical capabilities for biopharmaceutical applications.
The acquisition is expected to have a negligible impact on Waters' income statement over the next 12 months.
Waters Corporation (NYSE:WAT) announced that CEO Udit Batra will participate in a fireside chat at the Jefferies Global Healthcare Conference on June 4th, 2025, at 8:45AM Eastern Time. The event will be webcast live on Waters' Investor Relations website, with a replay available for 90 days.
Waters Corporation is a global leader in analytical instruments, separations technologies, and software for life, materials, food, and environmental sciences. With over 65 years of experience and 7,600+ employees across 100+ countries, the company collaborates with customers in laboratories, manufacturing sites, and hospitals to advance scientific innovation.
Waters (NYSE:WAT) has announced its upcoming first quarter 2025 earnings conference call, scheduled for Tuesday, May 6th, 2025 at 8:00 a.m. Eastern Time. The presentation will be accessible through a live webcast on the company's Investor Relations website, with replay availability until June 3rd, 2025.
Waters is a global leader in analytical instruments, separations technologies, and software for life, materials, food, and environmental sciences. The company employs 7,600 people across 100+ countries, working with customers in laboratories, manufacturing sites, and hospitals to advance scientific benefits.
Waters (NYSE:WAT) has expanded its Alliance™ iS Bio HPLC product line with integrated photodiode array (PDA) detection, enhancing capabilities for biopharmaceutical development and Quality Control laboratories. The system delivers significant improvements including:
- Up to 80x boost in sensitivity with MaxPeak™ Premier columns
- Over 3x improvement in day-to-day reproducibility
- Reduction in carryover by up to two orders of magnitude
- 40% reduction in common user errors
The platform is designed to simplify laboratory workflows and reduce out-of-specification results. All configurations are controlled by Waters Empower™ Chromatography Data System and support LIMS connectivity. The system has earned ACT Ecolabels from My Green Lab for sustainable manufacturing practices.